Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
IJMS | Free Full-Text | Autoimmune Responses in Oncology: Causes and Significance
Immune-Cell-Derived Exosomes for Cancer Therapy | Molecular Pharmaceutics
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy | Signal Transduction and Targeted Therapy
Frontiers | The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing: Molecular Therapy - Methods & Clinical Development
IJMS | Free Full-Text | The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
Frontiers | Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
What Are Immune Checkpoints?
Current Oncology | Free Full-Text | Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Elevated tumor markers for monitoring tumor response to immunotherapy - ScienceDirect
DNA Methylation and Anticancer Drug Resistance in Gynecological Tumors
Cancers | Free Full-Text | NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
T follicular helper cells in cancer: Trends in Cancer
Systemic immunity in cancer | Nature Reviews Cancer
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer | Scientific Reports
Biology | Free Full-Text | Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Cells | Free Full-Text | The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
Cancer immunology - Wikipedia
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer | Cell Death & Disease
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity | Cell Research
